These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7812271

  • 1. Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells.
    Kirikae T, Schade FU, Kirikae F, Qureshi N, Takayama K, Rietschel ET.
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):237-43. PubMed ID: 7812271
    [Abstract] [Full Text] [Related]

  • 2. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
    Kirikae F, Kirikae T, Qureshi N, Takayama K, Morrison DC, Nakano M.
    Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746
    [Abstract] [Full Text] [Related]

  • 3. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS.
    Jarvis BW, Lichenstein H, Qureshi N.
    Infect Immun; 1997 Aug; 65(8):3011-6. PubMed ID: 9234747
    [Abstract] [Full Text] [Related]

  • 4. Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells.
    Kutuzova GD, Albrecht RM, Erickson CM, Qureshi N.
    J Immunol; 2001 Jul 01; 167(1):482-9. PubMed ID: 11418686
    [Abstract] [Full Text] [Related]

  • 5. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.
    Takayama K, Qureshi N, Beutler B, Kirkland TN.
    Infect Immun; 1989 Apr 01; 57(4):1336-8. PubMed ID: 2784418
    [Abstract] [Full Text] [Related]

  • 6. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.
    Zuckerman SH, Qureshi N.
    Infect Immun; 1992 Jul 01; 60(7):2581-7. PubMed ID: 1612727
    [Abstract] [Full Text] [Related]

  • 7. Grain dust-induced lung inflammation is reduced by Rhodobacter sphaeroides diphosphoryl lipid A.
    Jagielo PJ, Quinn TJ, Qureshi N, Schwartz DA.
    Am J Physiol; 1998 Jan 01; 274(1):L26-31. PubMed ID: 9458797
    [Abstract] [Full Text] [Related]

  • 8. Diphosphoryl lipid A from Rhodobacter sphaeroides transiently activates NF-kappa B but inhibits lipopolysaccharide induction of kappa light chain and Oct-2 in the B-cell lymphoma line 70Z/3.
    Lawrence O, Rachie N, Qureshi N, Bomsztyk K, Sibley CH.
    Infect Immun; 1995 Mar 01; 63(3):1040-6. PubMed ID: 7868225
    [Abstract] [Full Text] [Related]

  • 9. Modulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431.
    Manthey CL, Perera PY, Qureshi N, Stütz PL, Hamilton TA, Vogel SN.
    Infect Immun; 1993 Aug 01; 61(8):3518-26. PubMed ID: 8335383
    [Abstract] [Full Text] [Related]

  • 10. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice.
    Qureshi N, Takayama K, Kurtz R.
    Infect Immun; 1991 Jan 01; 59(1):441-4. PubMed ID: 1987057
    [Abstract] [Full Text] [Related]

  • 11. Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A.
    Lei MG, Qureshi N, Morrison DC.
    Immunol Lett; 1993 Jun 01; 36(3):245-50. PubMed ID: 7690343
    [Abstract] [Full Text] [Related]

  • 12. Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.
    Kirkland TN, Qureshi N, Takayama K.
    Infect Immun; 1991 Jan 01; 59(1):131-6. PubMed ID: 1898897
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages.
    Manthey CL, Qureshi N, Stütz PL, Vogel SN.
    J Exp Med; 1993 Aug 01; 178(2):695-702. PubMed ID: 8101863
    [Abstract] [Full Text] [Related]

  • 14. Modulation of lipopolysaccharide binding to human granulocytes.
    Weersink AJ, Van Kessel KP, Van der Tol ME, Verhoef J.
    Immunology; 1994 Dec 01; 83(4):617-23. PubMed ID: 7533136
    [Abstract] [Full Text] [Related]

  • 15. Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products.
    Lei MG, Tan X, Qureshi N, Morrison DC.
    Infect Immun; 2005 Dec 01; 73(12):8136-43. PubMed ID: 16299308
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide-antagonizing effects of diphosphoryl lipid A from Rhodobacter sphaeroides (Rs-DPLA).
    Hofman J, Qureshi N, Takayama K, Kalin N, Manthey CL, Vogel SN, Lei MG, Morrison DC.
    Prog Clin Biol Res; 1994 Dec 01; 388():95-106. PubMed ID: 7831379
    [No Abstract] [Full Text] [Related]

  • 17. Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.
    Perera PY, Qureshi N, Christ WJ, Stütz P, Vogel SN.
    Infect Immun; 1998 Jun 01; 66(6):2562-9. PubMed ID: 9596717
    [Abstract] [Full Text] [Related]

  • 18. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction.
    Kirikae T, Schade FU, Zähringer U, Kirikae F, Brade H, Kusumoto S, Kusama T, Rietschel ET.
    FEMS Immunol Med Microbiol; 1994 Jan 01; 8(1):13-26. PubMed ID: 8156049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.